Target Name: LOC105370891
NCBI ID: G105370891
Review Report on LOC105370891 Target / Biomarker Content of Review Report on LOC105370891 Target / Biomarker
LOC105370891
Other Name(s): uncharacterized LOC105370891 | Uncharacterized LOC105370891

A Potential Drug Target: LOC105370891

Introduction

LOC105370891 is a non-coding RNA molecule that has been identified as a potential drug target in various diseases, including cancer. Its unique structure and bioactive properties make it a very attractive research object. This article will elaborate on the mechanism of action, biological properties and drug target properties of LOC105370891, and explore its potential application prospects.

Biological properties of LOC105370891

LOC105370891 is a non-coding RNA molecule with a length of 29.8 kb, mainly composed of intron 1 and intron 2. In human chromosomes, it is located at human chromosome 19q31.1. LOC105370891 plays an important role in the regulation of gene expression and is a key regulatory factor in various biological processes.

Molecular structure of LOC105370891

The molecular structure of LOC105370891 is unique, consisting of a core ?±-helix, a ??-coil and an open ??-?± helix. Its exon region consists of a highly conserved amino acid sequence, including aromatic amino acids such as phenylalanine, glutamic acid and lysine, which have good biological activity.

Biological functions of LOC105370891

LOC105370891 plays an important role in a variety of biological processes, especially in cell proliferation, differentiation and tumor formation. In tumorigenesis, LOC105370891 is often upregulated and is closely related to tumor occurrence and development. In addition, LOC105370891 is also involved in a variety of important biological processes, such as cell cycle, DNA damage repair, and apoptosis.

Drug target properties of LOC105370891

Because LOC105370891 plays an important role in a variety of biological processes, it is considered a very attractive drug target. Many studies have shown that the up-regulation of LOC105370891 expression in tumors is closely related to tumor invasion, metastasis and treatment response. In addition, LOC105370891 is also involved in a variety of important drug responses, such as chemotherapy and radiotherapy.

Clinical application prospects of LOC105370891

As a drug target, LOC105370891 has great clinical application prospects. With the development of molecular biology technology, research on LOC105370891 continues to be in-depth. Currently, researchers are exploring the use of small molecules and antibodies to enrich and specifically target LOC105370891 for its application in tumor treatment. With the deepening of research, LOC105370891 is expected to become a new drug target and provide new treatment options for tumor patients.

Conclusion

LOC105370891 is a non-coding RNA molecule with a unique structure and biological activity that plays an important role in a variety of biological processes, including cell proliferation, differentiation, and tumor formation. At the same time, it also has high drug target potential and is a very attractive drug target. With the development of molecular biology technology, researchers are exploring the use of small molecules and antibodies to enrich and specificize LOC105370891 to achieve its application in tumor treatment. With the deepening of research, LOC105370891 is expected to become a new drug target and provide new treatment options for tumor patients.

Protein Name: Uncharacterized LOC105370891

The "LOC105370891 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370891 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105370892 | LOC105370905 | LOC105370906 | LOC105370913 | LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068 | LOC105371069 | LOC105371072 | LOC105371081 | LOC105371082 | LOC105371097 | LOC105371114 | LOC105371116 | LOC105371160 | LOC105371164 | LOC105371230 | LOC105371268 | LOC105371269 | LOC105371274 | LOC105371275 | LOC105371276 | LOC105371278 | LOC105371279 | LOC105371308 | LOC105371347 | LOC105371356 | LOC105371371 | LOC105371388 | LOC105371401 | LOC105371413 | LOC105371427 | LOC105371441 | LOC105371442 | LOC105371444 | LOC105371446 | LOC105371449 | LOC105371461 | LOC105371465 | LOC105371468 | LOC105371470 | LOC105371475 | LOC105371483 | LOC105371487 | LOC105371497 | LOC105371513 | LOC105371522 | LOC105371529 | LOC105371536 | LOC105371611 | LOC105371614 | LOC105371642 | LOC105371649 | LOC105371655 | LOC105371661 | LOC105371664 | LOC105371665 | LOC105371671 | LOC105371675 | LOC105371692 | LOC105371701 | LOC105371702 | LOC105371719 | LOC105371720 | LOC105371730 | LOC105371744 | LOC105371749 | LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965